These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11593392)

  • 1. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.
    Fulda S; Küfer MU; Meyer E; van Valen F; Dockhorn-Dworniczak B; Debatin KM
    Oncogene; 2001 Sep; 20(41):5865-77. PubMed ID: 11593392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Grotzer MA; Eggert A; Zuzak TJ; Janss AJ; Marwaha S; Wiewrodt BR; Ikegaki N; Brodeur GM; Phillips PC
    Oncogene; 2000 Sep; 19(40):4604-10. PubMed ID: 11030149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.
    Fulda S; Debatin KM
    Oncogene; 2002 Apr; 21(15):2295-308. PubMed ID: 11948413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.
    Fulda S; Debatin KM
    Oncogene; 2006 Aug; 25(37):5125-33. PubMed ID: 16607283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.
    Eramo A; Pallini R; Lotti F; Sette G; Patti M; Bartucci M; Ricci-Vitiani L; Signore M; Stassi G; Larocca LM; Crinò L; Peschle C; De Maria R
    Cancer Res; 2005 Dec; 65(24):11469-77. PubMed ID: 16357155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB.
    Yang X; Merchant MS; Romero ME; Tsokos M; Wexler LH; Kontny U; Mackall CL; Thiele CJ
    Cancer Res; 2003 Mar; 63(5):1122-9. PubMed ID: 12615731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Hopkins-Donaldson S; Bodmer JL; Bourloud KB; Brognara CB; Tschopp J; Gross N
    Cancer Res; 2000 Aug; 60(16):4315-9. PubMed ID: 10969767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP; Zisman A; Bonavida B
    Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells.
    Jönsson G; Paulie S; Grandien A
    Anticancer Res; 2003; 23(2B):1213-8. PubMed ID: 12820373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P
    Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A; Grotzer MA; Zuzak TJ; Wiewrodt BR; Ho R; Ikegaki N; Brodeur GM
    Cancer Res; 2001 Feb; 61(4):1314-9. PubMed ID: 11245427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.
    Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N
    Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
    Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
    Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
    Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
    Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.